These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21048562)

  • 1. Evaluation of acute hepatitis C infection surveillance --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(43):1407-10. PubMed ID: 21048562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of national malaria surveillance system with the national notifiable diseases surveillance system in the United States.
    Hwang J; McClintock S; Kachur SP; Slutsker L; Arguin P
    J Public Health Manag Pract; 2009; 15(4):345-51. PubMed ID: 19525779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in nationally notifiable diseases--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jan; 54(1):9-11. PubMed ID: 15647725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiologic summary of the hepatitis C epidemic in Minnesota.
    Fong F
    Minn Med; 2003 Jun; 86(6):46-51. PubMed ID: 12834214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.
    Gasiorowicz M; Hurie M; Russell A; Hoxie N; Vergeront J
    WMJ; 2006 Jan; 105(1):34-9. PubMed ID: 16676489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of varicella reporting to the National Notifiable Disease Surveillance System--United States, 1972-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(3):55-8. PubMed ID: 9935144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of hepatitis C in the United States.
    Kim WR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S30-4. PubMed ID: 12407574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
    Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
    Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting race and ethnicity data--National Electronic Telecommunications System for Surveillance, 1994-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Apr; 48(15):305-12. PubMed ID: 10227798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hepetitis C infection, ERHA/HSE Eastern region.
    Meara MO; Barry J; Mullen L
    Ir Med J; 2007 Feb; 100(2):365-6. PubMed ID: 17432812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting of race and ethnicity in the National Notifiable Diseases Surveillance System, 1990.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(35):653-7. PubMed ID: 1508131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C virus infection among clients of HIV counseling and testing sites--Connecticut, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(27):577-81. PubMed ID: 11475165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: changes in notifiable disease surveillance data--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(42):824-36. PubMed ID: 8413172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatitis C.
    Alter MJ
    Hepatology; 1997 Sep; 26(3 Suppl 1):62S-65S. PubMed ID: 9305666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completeness and timeliness of reporting of meningococcal disease--Maine, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(7):169-72. PubMed ID: 19247263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of acute viral hepatitis data quality using two methodologies, 2005-2007.
    Iqbal K; Klevens RM; Jiles R
    Public Health Rep; 2012; 127(6):591-7. PubMed ID: 23115384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic--Nevada, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):513-7. PubMed ID: 18480743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.